Company Data
Merus N.V.
Ticker
MRUS
Current Price
$65.145 -1.44%
Market Cap
$4.9B
Price Target
Refer to Report
Volume
260.1K
52wk Range
$33.19 - $69.2
Overview
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus operates in one reportable segment, which comprises the discovery and development of innovative bispecific therapeutics.